title: Treatment of haemorrhoids at the Moscow Research Institute of Proctology.
abstract: The article sums up experience acquired with the treatment of more than 4,000 patients with haemorrhoids at the Research Institute of Proctology (Moscow). The pattern that emerges is that only about 30% of patients with haemorrhoids should be subjected to radical haemorrhoidectomy. Others can be cured on conservative lines, including sclerosing injections. Two modifications of haemorrhoidectomy are described which have been developed at the Research Institute of Proctology (Moscow). Long-term results of haemorrhoidectomy have been examined in nearly 1,500 patients. In the post-operative period of five and more years, 3.78% of patients had recurrences.
authors.affiliation: Research Institute of Proctology, Moscow, USSR.
authors.forename: Y V
authors.initials: YV
authors.lastname: Dultsev
authors.forename: V L
authors.initials: VL
authors.lastname: Rivkin
mesh_terms: D000285:Administration, Rectal; D003131:Combined Modality Therapy; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy; D006484:Hemorrhoids / Q000601:surgery / Q000628:therapy*; D006801:Humans; D008297:Male; D009824:Ointments; D010447:Peptide Hydrolases / Q000008:administration & dosage; D019800:Phenol; D010636:Phenols / Q000008:administration & dosage; D011343:Procaine / Q000008:administration & dosage; D012008:Recurrence; D012597:Sclerosing Solutions; D013488:Suppositories
chemical_list: D009824:Ointments; D010636:Phenols; D012597:Sclerosing Solutions; D013488:Suppositories; D019800:Phenol; D011343:Procaine; D010447:Peptide Hydrolases